Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease.
Trestle Biotherapeutics's investors include Draper Associates, Y Combinator, Acequia Capital (AceCap), Sahin Boydas, Asymmetry Ventures.
Trestle Biotherapeutics is headquartered in San Diego, United States.
Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease.
Trestle Biotherapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trestle Biotherapeutics — Funding & Investors." VCBacked, June 12, 2023, https://www.vcbacked.co/company/trestle-biotherapeutics. Accessed August 14, 2026.
VCBacked. (2023). Trestle Biotherapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trestle-biotherapeutics
{{cite web |title=Trestle Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trestle-biotherapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated